This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: 89Bio, Inc.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovations by Patrick Mengyuan Liu
Introduction
Patrick Mengyuan Liu is an accomplished inventor based in Rockville, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of peptide conjugates. His work focuses on enhancing the therapeutic potential of Fibroblast Growth Factor-21 (FGF-21).
Latest Patents
Patrick holds a patent for "Mutant FGF-21 peptide pegylated conjugates and uses thereof." This invention relates to a mutant FGF-21 peptide conjugate that includes a PEG moiety attached via a glycosyl linker. The patent outlines methods for producing this conjugate and describes its applications in pharmaceutical compositions.
Career Highlights
Patrick is currently employed at 89Bio, Inc., where he continues to innovate in the field of biotechnology. His expertise in peptide conjugates has positioned him as a valuable asset to his team and the company.
Collaborations
One of his notable coworkers is Karla K. Kopec, with whom he collaborates on various projects within the company.
Conclusion
Patrick Mengyuan Liu's contributions to biotechnology through his innovative patents and work at 89Bio, Inc. highlight his role as a leading inventor in the field. His research on FGF-21 peptide conjugates has the potential to advance therapeutic applications significantly.